CDT Equity Inc.

CDT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001896212

Other share classesCDTTW

Price chart

Open-market purchases and sales by CDT insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 2, 20266:12 PM ETAug 28, 2026Regan AndrewChief Executive OfficerSSaleCommon Stock−290––5.69M0.0%SEC
Jun 23, 20266:40 PM ETJun 18, 2026Taylor Mark Andrew and 2 others10% OwnerSSaleCommon Stock−2.07M$1.4244−$2.95M0−100.0%SEC
Oct 7, 20247:38 PM ETOct 3 – Oct 7, 2024Stockton Ltd and 3 others10% OwnerSSaleCommon Stock, par value $0.0001 per share−3.81M$0.1033−$393.44K6.09M−38.5%SEC
Oct 2, 20245:02 PM ETSep 30 – Oct 2, 2024Stockton Ltd and 3 others10% OwnerSSaleCommon Stock, par value $0.0001 per share−2.6M$0.1145−$297.64K9.9M−20.8%SEC
Sep 19, 20245:01 PM ETJul 3 – Jul 17, 2024Regan Andrew and 2 othersDirector, 10% OwnerSSaleCommon Stock−15.3M$0.3001−$4.59M177.63K−98.9%SEC

The largest institutional positions in CDT at the end of Q2 2026.

Institutions holding CDT in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
JANE STREET GROUP, LLC61,190$34.27K0.00%+61,190New
CITADEL ADVISORS LLC32,295$18.09K0.00%+32,295New
Virtu Financial LLC27,244$15K0.00%+27,244New
GEODE CAPITAL MANAGEMENT, LLC16,739$9.37K0.00%+16,739New
XTX Topco Ltd12,916$7.23K0.00%+12,916New